Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells.

M.C. Minnema; M.S. van der Veer; M.I. Aarts-Riemens; M.E. Emmelot; T. Mutis; H.M. Lokhorst

Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells.

Translated title of the contribution: Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells.

M.C. Minnema
, M.S. van der Veer
, M.I. Aarts-Riemens
, M.E. Emmelot
, T. Mutis
, H.M. Lokhorst

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells.
Original language	Undefined/Unknown
Pages (from-to)	605-607
Number of pages	3
Journal	Leukemia
Volume	23
Issue number	3
Publication status	Published - 2009

Cite this

@article{efa774a436a34ba9acd9da572737c01f,

title = "Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells.",

author = "M.C. Minnema and \{van der Veer\}, M.S. and M.I. Aarts-Riemens and M.E. Emmelot and T. Mutis and H.M. Lokhorst",

year = "2009",

language = "Undefined/Unknown",

volume = "23",

pages = "605--607",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "3",

}

Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells. / Minnema, M.C.; van der Veer, M.S.; Aarts-Riemens, M.I. et al.
In: Leukemia, Vol. 23, No. 3, 2009, p. 605-607.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells.

AU - Minnema, M.C.

AU - van der Veer, M.S.

AU - Aarts-Riemens, M.I.

AU - Emmelot, M.E.

AU - Mutis, T.

AU - Lokhorst, H.M.

PY - 2009

Y1 - 2009

M3 - Article

SN - 0887-6924

VL - 23

SP - 605

EP - 607

JO - Leukemia

JF - Leukemia

IS - 3

ER -